Kingdon Capital Management, L.L.C. Heron Therapeutics, Inc. Call Options Transaction History

Kingdon Capital Management, L.L.C.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 14, 2019	SELL	$23.15 - $28.34 $1.54 Million - $1.89 Million	-66,600 Reduced 30.75%	150,000 $3.67 Million
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $4.83 Million - $7.69 Million	-183,100 Reduced 45.81%	216,600 $8.42 Million
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $281,979 - $440,640	-15,300 Reduced 3.69%	399,700 $11 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $6.08 Million - $6.99 Million	415,000	415,000 $6.7 Million

173

114M

32.4K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $291M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.